Regulatory Agency Reform
Robert discusses the troubling financial ties between regulatory agencies and pharmaceutical companies, highlighting how these relationships compromise public health priorities. He emphasizes the need to eliminate conflicts of interest, particularly the revolving doors between the industry and agencies like the FDA and NIH. By advocating for transparency and accountability, he aims to reshape the focus of these organizations back to improving public health rather than serving corporate interests.In this clip
From this podcast
The Doctor's Farmacy with Mark Hyman, M.D.
Robert Kennedy Jr: Power, Corruption, Freedom, & The Chronic Disease Epidemic Within America
Related Questions